Zions Bancorporation’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $35.4K | Sell |
96
-63
| -40% | -$26.4K | ﹤0.01% | 450 |
|
|
2024
Q3 | $82.7K | Sell |
159
-34
| -18% | -$18.2K | 0.01% | 390 |
|
|
2024
Q2 | $105K | Sell |
193
-45
| -19% | -$23.8K | 0.01% | 375 |
|
|
2024
Q1 | $123K | Sell |
238
-61
| -20% | -$30.3K | 0.01% | 350 |
|
|
2023
Q4 | $141K | Sell |
299
-7
| -2% | -$3.24K | 0.01% | 339 |
|
|
2023
Q3 | $133K | Hold |
306
| – | – | 0.01% | 329 |
|
|
2023
Q2 | $136K | Sell |
306
-280
| -48% | -$129K | 0.01% | 330 |
|
|
2023
Q1 | $269K | Sell |
586
-177
| -23% | -$84.2K | 0.02% | 289 |
|
|
2022
Q4 | $391K | Buy |
763
+161
| +27% | +$81.7K | 0.03% | 261 |
|
|
2022
Q3 | $273K | Sell |
602
-19
| -3% | -$9.09K | 0.03% | 278 |
|
|
2022
Q2 | $300K | Sell |
621
-272
| -30% | -$135K | 0.03% | 276 |
|
|
2022
Q1 | $439K | Buy |
893
+306
| +52% | +$140K | 0.04% | 255 |
|
|
2021
Q4 | $272K | Sell |
587
-58
| -9% | -$24.4K | 0.02% | 280 |
|
|
2021
Q3 | $240K | Buy |
645
+59
| +10% | +$22.4K | 0.02% | 285 |
|
|
2021
Q2 | $224K | Hold |
586
| – | – | 0.02% | 283 |
|
|
2021
Q1 | $210K | Buy |
586
+293
| +100% | +$94.2K | 0.02% | 272 |
|
|
2020
Q4 | $94K | Buy |
293
+10
| +4% | +$3.07K | 0.01% | 323 |
|
|
2020
Q3 | $76K | Sell |
283
-1
| -0.4% | -$269 | 0.01% | 311 |
|
|
2020
Q2 | $75K | Buy |
284
+1
| +0.4% | +$267 | 0.01% | 297 |
|
|
2020
Q1 | $64K | Sell |
283
-214
| -43% | -$58.3K | 0.01% | 298 |
|
|
2019
Q4 | $150K | Sell |
497
-92
| -16% | -$25.3K | 0.02% | 273 |
|
|
2019
Q3 | $141K | Buy |
+589
| New | +$161K | 0.02% | 294 |
|
|
2018
Q4 | – | Sell |
-841
| Closed | -$230K | – | 578 |
|
|
2018
Q3 | $230K | Buy |
+841
| New | +$218K | 0.05% | 156 |
|
|
2017
Q4 | – | Sell |
-515
| Closed | -$98K | – | 719 |
|
|
2017
Q3 | $98K | Buy |
515
+491
| +2,046% | +$93.4K | 0.01% | 435 |
|
|
2017
Q2 | $5K | Sell |
24
-36
| -60% | -$6.47K | ﹤0.01% | 434 |
|
|
2017
Q1 | $10K | Sell |
60
-207
| -78% | -$32.9K | ﹤0.01% | 366 |
|
|
2016
Q4 | $39K | Buy |
267
+19
| +8% | +$2.54K | 0.01% | 273 |
|
|
2016
Q3 | $31K | Sell |
248
-8
| -3% | -$1.03K | 0.01% | 296 |
|
|
2016
Q2 | $34K | Buy |
256
+1
| +0.4% | +$137 | 0.01% | 257 |
|
|
2016
Q1 | $37K | Buy |
255
+5
| +2% | +$668 | 0.01% | 291 |
|
|
2015
Q4 | $31K | Buy |
250
+33
| +15% | +$4.55K | 0.01% | 279 |
|
|
2015
Q3 | $29K | Buy |
+217
| New | +$32.6K | 0.01% | 286 |
|
|
2015
Q2 | – | Sell |
-210
| Closed | -$32K | – | 401 |
|
|
2015
Q1 | $32K | Buy |
+210
| New | +$29.9K | 0.01% | 287 |
|
Other funds holding ELV
Zions Bancorporation's ELV Position: Q4 2024 in Review
Zions Bancorporation reduced its Elevance Health (ELV) stake by 40% in Q4 2024, selling an estimated $26.4K and leaving 96 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #450.
Zions Bancorporation first reported a position in ELV in Q1 2015 and has held it in 33 quarters since. The position peaked at $439K in Q1 2022. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.
- Zions Bancorporation held 96 shares of Elevance Health worth $35.4K as of Q4 2024.
- Zions Bancorporation sold 63 Elevance Health shares in Q4 2024, an estimated $26.4K.
- Elevance Health made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #450 holding.
- Zions Bancorporation first reported a position in Elevance Health in Q1 2015 and has held it in 33 quarters since.
- Zions Bancorporation's Elevance Health position peaked at $439K in Q1 2022.
- 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.